← Leaderboards
Matthias Gromeier
Duke University
$11,871,021
Attributed
$13,343,733
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,837,988 · 12
By mechanism
R01$9,605,138 · 5
P01$2,494,255 · 1
P50$2,403,155 · 2
R21$1,235,440 · 3
R55$100,000 · 1
Top collaborators
- Smita K Nair8 shared
- David M. Ashley1 shared
Most similar at Duke University
Same institution · by research overlap
- Darell D Bigner$25,397,506
- Tatiana Segura$14,175,920
- John H Sampson$43,413,436
- Michael Clavon Brown$1,028,443
- James E Herndon$5,648,307
Others in their field
Top investigators on “Recombinants”
- David Heimbrook · Leidos Biomedical Research, Inc.$147,165,789
- Barton F Haynes · Duke University$134,153,827
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Stanley B Prusiner · University Of California San Francisco$55,441,768
- Thomas William Geisbert · Boston University Medical Campus$50,907,172
- Larry Arthur$46,063,806
Research focus
RecombinantsMalignant NeoplasmsCellsHuman PoliovirusGliomaViralTumorClinical TrialsResponseSignal TransductionGlioblastomaMediatingMalignant GliomaTissuesInfectionTranslationsRhinovirusInsightCancer CellImmuneTumor AntigensNeoplastic CellInvestigationImmunotherapy
Grant awards (54)
Resolving Spatiotemporal Dynamics of Recombinant Poliovirus Immunotherapy$455,171
R01 · FY2025 · CA · contact PI
Innate Antiviral Signals for Cancer Immunotherapy$402,500
R01 · FY2025 · NS · contact PI
Innate Antiviral Signals for Cancer Immunotherapy$390,425
R01 · FY2024 · NS · contact PI
Resolving Spatiotemporal Dynamics of Recombinant Poliovirus Immunotherapy$358,773
R01 · FY2024 · CA · contact PI
Resolving Spatiotemporal Dynamics of Recombinant Poliovirus Immunotherapy$73,640
R01 · FY2024 · CA · contact PI
Research Supplement to Promote Diversity in Health-Related Research$24,208
R01 · FY2024 · CA · contact PI
Innate Antiviral Signals for Cancer Immunotherapy$402,500
R01 · FY2023 · NS · contact PI
Resolving Spatiotemporal Dynamics of Recombinant Poliovirus Immunotherapy$377,656
R01 · FY2023 · CA · contact PI
Experimental Therapy for Brain Tumors$2,494,255
P01 · FY2022 · CA
Innate Antiviral Signals for Cancer Immunotherapy$350,000
R01 · FY2022 · NS · contact PI
Innate Antiviral Signals for Cancer Immunotherapy$350,000
R01 · FY2021 · NS · contact PI
Innate Antiviral Signals for Cancer Immunotherapy$350,000
R01 · FY2020 · NS · contact PI
Innate Antiviral Signals for Cancer Immunotherapy$350,000
R01 · FY2019 · NS · contact PI
Innate Antiviral Signals for Cancer Immunotherapy$350,000
R01 · FY2018 · NS · contact PI
Oncolytic Immunotherapy of Malignant Glioma$267,050
P50 · FY2018 · CA · contact PI
Oncolytic Immunotherapy of Malignant Glioma$248,157
P50 · FY2017 · CA · contact PI
Targeting Translation Control in Malignant Glioma$253,655
R01 · FY2016 · CA · contact PI
Oncolytic Immunotherapy of Malignant Glioma$211,798
P50 · FY2016 · CA · contact PI
Targeting Translation Control in Malignant Glioma$253,655
R01 · FY2015 · CA · contact PI
Oncolytic Immunotherapy of Malignant Glioma$227,234
P50 · FY2015 · CA · contact PI
Targeting Translation Control in Malignant Glioma$246,045
R01 · FY2014 · CA · contact PI
Oncolytic Immunotherapy of Malignant Glioma$224,888
P50 · FY2014 · CA · contact PI
Oncolytic Virotherapy of Meningeal Cancer$295,150
R01 · FY2013 · CA · contact PI
Targeting Translation Control in Malignant Glioma$238,436
R01 · FY2013 · CA · contact PI
Oncolytic Virotherapy of Meningeal Cancer$313,989
R01 · FY2012 · CA · contact PI
Targeting Translation Control in Malignant Glioma$249,873
R01 · FY2012 · CA · contact PI
Oncolytic Virotherapy of Meningeal Cancer$313,989
R01 · FY2011 · CA · contact PI
Targeting Translation Control in Malignant Glioma$258,757
R01 · FY2011 · CA · contact PI
Oncolytic Virotherapy of Meningeal Cancer$323,700
R01 · FY2010 · CA · contact PI
Targeting Translation Control in Malignant Glioma$266,760
R01 · FY2010 · CA · contact PI
Enterovirus Vectors with Respiratory Tropism for Cancer Immunotherapy$234,000
R21 · FY2010 · NS · contact PI
Oncolytic Virotherapy of Meningeal Cancer$323,700
R01 · FY2009 · CA · contact PI
Targeting Translation Control in Malignant Glioma$266,760
R01 · FY2009 · CA · contact PI
Transgenic Mouse Model for the Common Cold$234,000
R21 · FY2009 · HL · contact PI
Enterovirus Vectors with Respiratory Tropism for Cancer Immunotherapy$195,000
R21 · FY2009 · NS · contact PI
Targeting Translation Control in Malignant Glioma$266,760
R01 · FY2008 · CA · contact PI
CNS Tumor Treatment Exploiting Viral Neuropathogenesis$254,741
P50 · FY2008 · NS · contact PI
Transgenic Mouse Model for the Common Cold$195,000
R21 · FY2008 · HL · contact PI
Targeting Translation Control in Malignant Glioma$266,333
R01 · FY2007 · CA · contact PI
CNS Tumor Treatment Exploiting Viral Neuropathogenesis$262,376
P50 · FY2007 · NS · contact PI
CNS Tumor Treatment Exploiting Viral Neuropathogenesis$235,637
P50 · FY2006 · NS · contact PI
Cell Type-Specific Viral Translation in the CNS$209,257
R01 · FY2006 · CA · contact PI
CNS Tumor Treatment Exploiting Viral Neuropathogenesis$235,637
P50 · FY2005 · NS
Cell Type-Specific Viral Translation in the CNS$219,450
R01 · FY2005 · CA
Cell Type-Specific Viral Translation in the CNS$50,224
R01 · FY2005 · CA
CNS Tumor Treatment Exploiting Viral Neuropathogenesis$235,637
P50 · FY2004 · NS
Cell Type-Specific Viral Translation in the CNS$219,450
R01 · FY2004 · CA
Genetically stable Picornavirus HIV Immunization vector$192,500
R21 · FY2004 · AI
Cell Type-Specific Viral Translation in the CNS$49,887
R01 · FY2004 · CA
Cell Type-Specific Viral Translation in the CNS$219,450
R01 · FY2003 · CA
Genetically stable Picornavirus HIV Immunization vector$184,940
R21 · FY2003 · AI
Cell Type-Specific Viral Translation in the CNS$48,613
R01 · FY2003 · CA
Cell Type-Specific Viral Translation in the CNS$216,372
R01 · FY2002 · CA
Cell Type Specific Viral Translation in the CNS$100,000
R55 · FY2001 · CA